PlainRecalls
FDA Drug Moderate Class II Ongoing

RECOMBINATE, [Antihemophilic Factor (Recombinant)], 5 mL vials, Rx Only, Takeda Pharmaceuticals USA, Cambridge, MA 02142, NDC: 00944-2843-01

Reported: August 13, 2025 Initiated: July 30, 2025 #D-0573-2025

Product Description

RECOMBINATE, [Antihemophilic Factor (Recombinant)], 5 mL vials, Rx Only, Takeda Pharmaceuticals USA, Cambridge, MA 02142, NDC: 00944-2843-01

Reason for Recall

CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.

Details

Recalling Firm
Cardinal Health Inc.
Units Affected
3 units
Distribution
Nationwide Within the U.S.
Location
Dublin, OH

Frequently Asked Questions

What product was recalled?
RECOMBINATE, [Antihemophilic Factor (Recombinant)], 5 mL vials, Rx Only, Takeda Pharmaceuticals USA, Cambridge, MA 02142, NDC: 00944-2843-01. Recalled by Cardinal Health Inc.. Units affected: 3 units.
Why was this product recalled?
CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 13, 2025. Severity: Moderate. Recall number: D-0573-2025.